TECH2AIM

Accepted

Active implantable medical devices are increasingly used for the treatment of pathologies with, in 2025, an estimated market of $ 30 billion. The emergence of new generations of AIMD requires miniaturization, communication and energy efficiency solutions. Tech2AIM thus aims to develop a BtoB sector of breakthrough technological components with high added value around the transfer of energy by ultrasound and the functionalization of titanium (radiofrequency communication and ECG electrodes).

Project benefits

There are no benefits for this project at this time

People involved in the project

Project leader

Member partner

Strategic business lines

Matériaux et composants pour l'électronique


Referent of the project

Nicolas POUSSET
Responsable Technique

07 86 53 38 70

nicolas.pousset-s2e2-ext@st.com

Centre val de loire